May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Age–Related Cataract in a Randomized Trial of Vitamin E in Women
Author Affiliations & Notes
  • W.G. Christen
    Medicine, Brigham & Womens Hosp/Harvard, Boston, MA
  • R.J. Glynn
    Medicine, Brigham & Womens Hosp/Harvard, Boston, MA
  • E.Y. Chew
    National Eye Institute, Bethesda, MD
  • J.E. Buring
    Medicine, Brigham & Womens Hosp/Harvard, Boston, MA
  • Footnotes
    Commercial Relationships  W.G. Christen, None; R.J. Glynn, None; E.Y. Chew, None; J.E. Buring, None.
  • Footnotes
    Support  NIH Grants CA47988, HL43851, and EY06633
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4137. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.G. Christen, R.J. Glynn, E.Y. Chew, J.E. Buring; Age–Related Cataract in a Randomized Trial of Vitamin E in Women . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4137.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine incidence of visually–significant age–related cataract and extraction in a randomized trial of vitamin E.

Methods: : The Women's Health Study was a randomized, double–blind, placebo–controlled trial of vitamin E (600 IU of natural–source vitamin E taken on alternate days) and low–dose aspirin (50 mg on alternate days) in the prevention of cancer and cardiovascular disease among 39,876 women aged 45 years or older. A total of 37,688 participants did not report cataract at baseline and were included in this analysis. Age–related cataract was defined as an incident, age–related lens opacity, responsible for a reduction in best–corrected visual acuity to 20/30 or worse, based on self–report confirmed by medical record review.

Results: : During an average of 10 years of treatment and follow–up, a total of 2,378 cataracts and 1,554 cataract extractions were confirmed. There were 1,160 cataracts in the vitamin E group and 1,218 cataracts in the placebo group (relative risk [RR], 0.96; 95% confidence interval [CI], 0.88–1.04). In analyses of cataract subtypes, there were no significant effects of vitamin E on incidence of nuclear (RR, 0.94; CI, 0.87–1.03), cortical (RR, 0.93; CI, 0.82–1.06), or posterior subcapsular cataract (RR, 1.00; CI, 0.87–1.16). For cataract extraction, there were 775 in the vitamin E group and 779 in the placebo group (RR, 1.01; CI, 0.91–1.11). In analyses of subtypes, there were no significant effects of vitamin E on extraction of nuclear (RR, 1.00; CI, 0.90–1.11), cortical (RR, 0.92; CI, 0.78–1.08), or posterior subcapsular cataract (RR, 1.08; CI, 0.92–1.27). For both cataract and cataract extraction, RRs did not vary significantly according to known risk factors for cataract including age, smoking, body mass index, and diabetes.

Conclusions: : These randomized trial data from a very large cohort of women indicate that ten years of alternate–day supplementation with 600 IU of natural–source vitamin E has no material beneficial or harmful effect on age–related cataract or cataract extraction.

Keywords: cataract • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • antioxidants 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×